Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,042 | 8,417 | 11,998 | 9,125 | 2,013 |
| Marketable Securities | 11,625 | 16,915 | 9,825 | 3,898 | 48,547 |
| Receivables | 1,406 | 602 | 168 | 1,235 | 533 |
| Inventories | 3,812 | 1,794 | 181 | 229 | 252 |
| TOTAL | $31,696 | $28,440 | $22,876 | $15,047 | $52,222 |
| Non-Current Assets | |||||
| PPE Net | 3,539 | 1,799 | 395 | 299 | 508 |
| Investments And Advances | 0 | 0 | 0 | 0 | 2,498 |
| Intangibles | 778 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 11,335 | 2,335 | 753 | 1,224 | 1,346 |
| TOTAL | $15,652 | $4,134 | $1,148 | $1,523 | $4,352 |
| Total Assets | $47,348 | $32,574 | $24,024 | $16,570 | $56,574 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,141 | 24 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,185 | 4,725 | 2,674 | 2,525 | 2,389 |
| Other current liabilities | 263 | 306 | 284 | N/A | N/A |
| TOTAL | $6,314 | $5,708 | $3,054 | $3,525 | $3,129 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,105 | 107 | N/A | N/A | 25,127 |
| Deferred Revenues | 8 | 42 | 96 | 1,000 | 740 |
| Other Non-Current Liabilities | 11,748 | 18,501 | 8,155 | 3,000 | 3,000 |
| TOTAL | $12,482 | $18,540 | $8,155 | $5,038 | $31,247 |
| Total Liabilities | $18,796 | $24,248 | $11,209 | $8,563 | $34,376 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 533 | 216 | 119 | 53 | 56 |
| Common Shares | 54 | 49 | 45 | 42 | 44 |
| Retained earnings | -211,825 | -207,171 | -178,366 | -167,257 | -151,550 |
| Other shareholders' equity | 827 | 622 | 0 | -1 | -19 |
| TOTAL | $28,552 | $8,326 | $12,815 | $8,007 | $22,198 |
| Total Liabilities And Equity | $47,348 | $32,574 | $24,024 | $16,570 | $56,574 |